NeuroProtect, Inc.’s mission is to create effective therapeutics for stroke.

We are a privately held subsidiary of VIROGENOMICS, Inc., a privately held Oregon-based biotechnology company. VIROGENOMIC’S business strategy is to identify and obtain the rights to early-stage technologies, and then manage and develop these technologies for drug discovery and development. Virogenomics’ executives have extensive experience in taking products through the FDA regulatory system. They have received FDA approval on four products for several previous companies.